BA
TDOC icon

Bridgewater Associates’s Teladoc Health TDOC Stock Holding History

Bridgewater Associates’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Buy
11,790
+50
+0.4% +$333 ﹤0.01% 996
2026
Q1 		$64K Sell
11,740
-622,739
-98% -$3.49M ﹤0.01% 991
2025
Q4 		$4.44M Buy
634,479
+150,730
+31% +$1.18M 0.02% 568
2025
Q3 		$3.74M Buy
483,749
+473,309
+4,534% +$3.69M 0.01% 559
2025
Q2 		$90.9K Sell
10,440
-2,358
-18% -$17.1K ﹤0.01% 585
2025
Q1 		$102K Sell
12,798
-16,078
-56% -$163K ﹤0.01% 661
2024
Q4 		$262K Sell
28,876
-83,930
-74% -$810K ﹤0.01% 644
2024
Q3 		$1.04M Sell
112,806
-123,580
-52% -$1.02M 0.01% 597
2024
Q2 		$2.31M Sell
236,386
-38,190
-14% -$466K 0.01% 504
2024
Q1 		$4.15M Sell
274,576
-37,273
-12% -$676K 0.02% 403
2023
Q4 		$6.72M Sell
311,849
-35,721
-10% -$659K 0.04% 322
2023
Q3 		$6.46M Buy
347,570
+26,070
+8% +$609K 0.04% 310
2023
Q2 		$8.14M Buy
321,500
+9,657
+3% +$243K 0.05% 225
2023
Q1 		$8.08M Sell
311,843
-12,453
-4% -$333K 0.05% 232
2022
Q4 		$7.67M Sell
324,296
-89,204
-22% -$2.41M 0.04% 282
2022
Q3 		$10.5M Sell
413,500
-9,331
-2% -$327K 0.05% 247
2022
Q2 		$14M Buy
422,831
+24,509
+6% +$1.04M 0.06% 266
2022
Q1 		$28.7M Buy
398,322
+96,930
+32% +$6.98M 0.12% 134
2021
Q4 		$27.7M Buy
301,392
+31,202
+12% +$3.73M 0.16% 106
2021
Q3 		$34.3M Sell
270,190
-8,368
-3% -$1.22M 0.19% 100
2021
Q2 		$46.3M Buy
278,558
+268,383
+2,638% +$43.5M 0.3% 65
2021
Q1 		$1.85M Sell
10,175
-18,142
-64% -$4.21M 0.02% 282
2020
Q4 		$5.66M Buy
+28,317
New +$5.76M 0.05% 180

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Bridgewater Associates's TDOC Position: Q2 2026 in Review

Bridgewater Associates increased its Teladoc Health (TDOC) stake by 0.43% in Q2 2026, buying an estimated $333 and bringing the position to 11,790 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Bridgewater Associates first reported a position in TDOC in Q4 2020 and has held it in 23 quarters since. The position peaked at $46.3M in Q2 2021. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Bridgewater Associates held 11,790 shares of Teladoc Health worth $100K as of Q2 2026.
  • Bridgewater Associates bought 50 Teladoc Health shares in Q2 2026, an estimated $333.
  • Teladoc Health made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #996 holding.
  • Bridgewater Associates first reported a position in Teladoc Health in Q4 2020 and has held it in 23 quarters since.
  • Bridgewater Associates's Teladoc Health position peaked at $46.3M in Q2 2021.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.